ABIVAX Company Profile

News Articles [16 Associated News Articles listed on BioPortfolio]

DGAP-News: ABIVAX Eventplan (deutsch)

ABIVAX Eventplan DGAP-News: ABIVAX / Schlagwort(e): Konferenz ABIVAX Eventplan 12.03.2018 / 20:30 Für den Inhalt der Mitteilung ist der Emittent verantwortlich. -----------------------------------...

Abivax Spots an Extra Benefit of its Potential HIV Cure

Further interrogation of Phase IIa data confirms that Abivax’s potential HIV cure not only reduces viral reservoir but it also has anti-inflammatory effects. Abivax targets the immune system to figh...

ABIVAX to Participate in “Corporate Access” Event in San Francisco, January 8 – 10, 2018

Regulatory News: ABIVAX (Euronext Paris: FR0012333284 – ABVX), a biotechnology company harnessing the immune system to develop a functional cure for HIV and trea...

Abivax starts enrolment in Phase IIa ulcerative colitis trial

Abivax has started patient enrolment in a Phase IIa clinical trial (ABX464-101) of its product candidate ABX464 for the treatment...Read More... The post Abivax starts enrolment in Phase IIa ulcerativ...

ABIVAX Upcoming Events

2017 Financial Results to be announced on March 16, 2018 Regulatory News: ABIVAX (Paris:ABVX) (Euronext Paris: FR0012333284 ABVX), a biotechnology company harnessing the immune system to develop a...

ABIVAX Announces Its Financial Calendar for 2018

Regulatory News: ABIVAX (Euronext Paris: FR0012333284 ABVX) (Paris:ABVX), a biotechnology company harnessing the immune system to develop a functional cure for HIV and treatments for inflammatory/...

VIDEO: Abivax CEO Highlights Pipeline Assets, Including Lead HIV Drug

Abivax CEO Dr. Hartmut Ehrlich talks to Scrip senior editor Lucie Ellis about the progress and next development steps for...    

ABIVAX's ABX464 Phase IIa Data confirm HIV Reservoir Reduction in Oral Presentation at 8th International Workshop on HIV Persistence During Therapy

Peer-reviewed Plenary Presentation ABX464 Reduces HIV Reservoir in Blood in Second Phase IIa Clinical Trial ABIVAX First-Ever to Show Statistically Significant (p New Anti-Inflammatory ABX464 Data...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

ABIVAX